IMPLICATIONS OF CXCR3 EXPRESSION ON MYELOID CELLS FOR IMMUNOTHERAPY OF CANCER AND MYELOID-M… Application WO-2024098072-A2 World Intellectual Property Organisation (WIPO) 10 May 2024
Synthetic immunomodulation with a CRISPR super-repressor in vivo Grant US-11884925-B2 United States of America 30 Jan 2024
PHOSPHOLIPID COMPOSITIONS COMPRISING EPA AND/OR DHA FOR AMELIORATING NEURODEGENERATION… Application WO-2024003711-A1 World Intellectual Property Organisation (WIPO) 04 Jan 2024
METHODS FOR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD) USING ADVANCED… Application WO-2023208816-A1 World Intellectual Property Organisation (WIPO) 02 Nov 2023